Pharmacokinetic study of sulfobutylether beta-cyclodextrin as an excipient of remdesivir
SBECD (Captisol®) with an average degree of substitution of 6.5 sulfobutylether functional groups (SBE = 6.5), is a solubility enhancer
Tag: MS/MS
A forum for researchers, students and applicants in the field of cyclodextrin technology